A versatile immunomodulated nanoCRISPR converter augments the susceptibility and visibility of tumors to the immune system
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, number 29, July 2025.
The significant study addresses a critical limitation in the treatment by immune control blocking (ICB)-the altered expression of MHC-I on the surfaces of tumor cells which restricts the anti-tumor immune responses. To overcome this challenge, we have developed Switch, a …
